🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a single-center, single-arm, open-label, self-controlled, phase I c...
Status
Completed
Location
West China Second University Hospital Ethics Committee
Start Date
2020-09-03
Trial ID
NCT05088174
Treatments Being Tested
This study use a single-center, randomized, open, three-cycle, self-control...
Status
Completed
Location
The third xiangya hospital Hospital,of central south university
Start Date
2018-07-14
Trial ID
NCT03603132
Treatments Being Tested
This open-label, randomized, two-period, two-treatment (single doses of 7.5...
Status
Completed
Location
West Hospital, Sichuan University
Start Date
2014-03
Trial ID
NCT02409394
Treatments Being Tested
To evaluate the efficacy and safety of hetrombopag in the treatment of thro...
Status
Unknown
Location
xianglin Yuan
Start Date
2022-10
Trial ID
NCT05575986
Treatments Being Tested
This study consists of two parts. Part 1 is a pilot BE study, and Part 2 is...
Status
Completed
Location
The People's Hospital Of Liaoning Province
Start Date
2021-06-25
Trial ID
NCT05088655
Treatments Being Tested
Randomized, controlled, open study to evaluate the efficacy and safety of H...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2023-07
Trial ID
NCT05944211
Treatments Being Tested
This study now plans to explore the efficacy and safety of hetrombopag in c...
Status
Completed
Location
Henan Cancer Hospital
Start Date
2022-09-21
Trial ID
NCT05394285
Treatments Being Tested
The title of this study is: A two-cohort, single-arm, exploratory Phase II ...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2025-11-30
Trial ID
NCT07243418
Treatments Being Tested
This study is a single-arm, exploratory, self-controlled clinical trial for...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2025-11-30
Trial ID
NCT07252375
Treatments Being Tested
Hetrombopag Olamine made by Jiangsu Hengrui Medicine co Ltd. has shown an e...
Status
Completed
Location
West China Hospital, Sichuan University
Start Date
2012-04
Trial ID
NCT01830660
Treatments Being Tested